Engineered immune cells take aim at Hard-to-Treat T-Cell cancers
NCT ID NCT07678307
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study tests a new treatment called nano CD5-CAR T cells for people with relapsed or refractory T-cell acute lymphoblastic leukemia or T-cell lymphoma. The therapy uses a patient's own immune cells, modified in a lab to recognize and attack cancer cells that carry the CD5 protein. The trial has two phases: the first checks safety and the best dose, and the second looks at how well the treatment works. Participants receive chemotherapy before a single infusion of the modified cells.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous nano CD5-CAR T cells
- What this could lead to
- If it works, this could offer a new treatment option for people with hard-to-treat T-cell cancers that have not responded to standard therapy.
- What could go wrong
- This is an early-phase trial with only 18 participants, so results may not apply broadly. Risks include fever, low blood pressure, and infection, and the therapy may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Personalized chemo dosing may boost survival in kids with High-Risk leukemia
- Engineered immune cells take aim at stubborn blood cancers
- Double-Barreled immune attack aims to wipe out T-ALL
- Chemotherapy showdown: which combo works best for T-Cell cancers in kids?
- Gene test spots hidden leukemia in kids
- Exercise during chemo: new study tests strength training for children with leukemia